Ziagen News and Research

RSS
Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Severe hypersensitivity reactions to anti-HIV drug occur through autoimmune mechanism

Severe hypersensitivity reactions to anti-HIV drug occur through autoimmune mechanism

Researchers identify new mechanism for drug-related autoimmune reactions

Researchers identify new mechanism for drug-related autoimmune reactions

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

NHGRI's new strategic plan to identify genetic bases of most single-gene disorders

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Shionogi-ViiV Healthcare initiates 572-Trii fixed-dose combination therapy study for HIV

Genocea announces close of $35 million Series B venture financing round

Genocea announces close of $35 million Series B venture financing round

Matrix's NDA for Abacavir Sulfate receives tentative FDA approval under PEPFAR

Matrix's NDA for Abacavir Sulfate receives tentative FDA approval under PEPFAR

Pathway Genomics' personal Genetic Health Report now available

Pathway Genomics' personal Genetic Health Report now available

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

ViiV Healthcare highlights S/GSK1349572, SELZENTRY and EPZICOM for HIV/AIDS at 17th CROI

GlaxoSmithKline pledges $97 million investment in AIDS drugs for Africa, allows South African drugmaker to produce generic second-line treatment

GlaxoSmithKline pledges $97 million investment in AIDS drugs for Africa, allows South African drugmaker to produce generic second-line treatment

GSK to supply antiretroviral drugs to Russia at discounted price

GSK to supply antiretroviral drugs to Russia at discounted price

FDA gives tentative approval for generic pediatric AIDS drug

FDA gives tentative approval for generic pediatric AIDS drug

FDA gives tentative approval to new generic AIDS drug

FDA gives tentative approval to new generic AIDS drug

Approval of fixed-dose combination treatments for HIV-1 infection

Approval of fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

FDA approves two fixed-dose combination treatments for HIV-1 infection

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.